Related references
Note: Only part of the references are listed.Effects of Dopamine D1-Like Receptor Ligands on Food-Cocaine Choice in Socially Housed Male Cynomolgus Monkeys
Paul W. Czoty et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2021)
Crystal structure of dopamine D1 receptor in complex with G protein and a non-catechol agonist
Bingfa Sun et al.
NATURE COMMUNICATIONS (2021)
Synthesis and dopamine receptor pharmacological evaluations on ring C ortho halogenated 1-phenylbenzazepines
Rajan Giri et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
Characterization of PF-6142, a Novel, Non-Catecholamine Dopamine Receptor D1 Agonist, in Murine and Nonhuman Primate Models of Dopaminergic Activation
Rouba Kozak et al.
FRONTIERS IN PHARMACOLOGY (2020)
Dopamine Receptor Subtypes, Physiology and Pharmacology: New Ligands and Concepts in Schizophrenia
Jean Claude Martel et al.
FRONTIERS IN PHARMACOLOGY (2020)
PF-06649751 efficacy and safety in early Parkinson's disease: a randomized, placebo-controlled trial
Robert Riesenberg et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2020)
Defining Structure-Functional Selectivity Relationships (SFSR) for a Class of Non-Catechol Dopamine D1 Receptor Agonists
Michael L. Martini et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Advances in Dopamine D1 Receptor Ligands for Neurotherapeutics
Daniel E. Felsing et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2019)
Identification of functional divergence sites in dopamine receptors of vertebrates
Juncai Xin et al.
COMPUTATIONAL BIOLOGY AND CHEMISTRY (2019)
Novel Strategies To Activate the Dopamine D1 Receptor: Recent Advances in Orthosteric Agonism and Positive Allosteric Modulation
Adrian Hall et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Impaired β-arrestin recruitment and reduced desensitization by non-catechol agonists of the D1 dopamine receptor
David L. Gray et al.
NATURE COMMUNICATIONS (2018)
Advances in dopamine receptor agonists for the treatment of Parkinson's disease
Fabrizio Stocchi et al.
EXPERT OPINION ON PHARMACOTHERAPY (2016)
Update 1 of: Recent Progress in Development of Dopamine Receptor Subtype-Selective Agents: Potential Therapeutics for Neurological and Psychiatric Disorders
Na Ye et al.
CHEMICAL REVIEWS (2013)
Dopamine D2 Receptor Occupancy and Cognition in Schizophrenia: Analysis of the CATIE Data
Hitoshi Sakurai et al.
SCHIZOPHRENIA BULLETIN (2013)
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
Nicholas A. Meanwell
JOURNAL OF MEDICINAL CHEMISTRY (2011)
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
Jean-Martin Beaulieu et al.
PHARMACOLOGICAL REVIEWS (2011)
The structure and function of G-protein-coupled receptors
Daniel M. Rosenbaum et al.
NATURE (2009)
Recent advances in the development of novel pharmacological agents for the treatment of cognitive impairments in schizophrenia
Robert W. Buchanan et al.
SCHIZOPHRENIA BULLETIN (2007)
Receptor affinities of dopamine D1 receptor-selective novel phenylbenzazepines
JL Neumeyer et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
Share Paper
